Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects
Conditions:   Stress Urinary Incontinence;   Fecal Incontinence Interventions:   Drug: Citalopram 40mg;   Drug: Reboxetine 8 mg;   Drug: Placebo oral tablet Sponsor:   University Hospital Bispebjerg and Frederiksberg Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 20, 2019 Category: Research Source Type: clinical trials

Neurobiological Processing of Emotions in Major Depression
Conditions:   Eye Movement Desensitization and Reprocessing;   Citalopram;   Neurobiological Processing;   Emotions;   fMRI;   HD-EEG Interventions:   Behavioral: EMDR;   Drug: Citalopram Sponsors:   University of Turin, Italy;   EMDR Europe Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 3, 2019 Category: Research Source Type: clinical trials

A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial
This article describes the protocol for a randomised controlled trial (ANTLER: ANTidepressants to prevent reLapse in dEpRession) to investigate the clinical effectiveness and cost-effectiveness in UK primary care of continuing on long-term maintenance antidepressants compared with a placebo in preventing relapse of depression in those who have taken antidepressants for more than 9  months and who are currently well enough to consider stopping maintenance treatment.Methods/designThe ANTLER trial is an individually randomised, double-blind, placebo-controlled trial in which participants are randomised to remain on act...
Source: Trials - June 3, 2019 Category: Research Source Type: clinical trials

A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects
Condition:   Healthy Interventions:   Drug: ACT541468;   Drug: ACT541468 placebo;   Drug: Citalopram Sponsor:   Idorsia Pharmaceuticals Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2019 Category: Research Source Type: clinical trials

A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects
Condition:   Healthy Interventions:   Drug: ACT541468;   Drug: ACT541468 placebo;   Drug: Citalopram Sponsor:   Idorsia Pharmaceuticals Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2019 Category: Research Source Type: clinical trials

A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female Subjects
Condition:   Healthy Interventions:   Drug: ACT541468;   Drug: ACT541468 placebo;   Drug: Citalopram Sponsor:   Idorsia Pharmaceuticals Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2019 Category: Research Source Type: clinical trials

Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders
Condition:   Major Depressive Disorder Intervention:   Drug: Citalopram 20mg or 40 mg (phase 2) Sponsor:   Ciusss de L'Est de l'Île de Montréal Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2019 Category: Research Source Type: clinical trials

A Study in People With Depression to Test the Effects of BI 1358894 on Parts of the Brain That Are Involved in Emotions
Condition:   Depressive Disorder, Major Interventions:   Drug: BI 1358894;   Drug: Placebo matching BI 1358894;   Drug: Citalopram Sponsor:   Boehringer Ingelheim Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2019 Category: Research Source Type: clinical trials